Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

How much does Forzinity (elamipretide) cost?

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

The short answer

Without insurance, SS-31 (elamipretide) runs about $66,000 per month depending on where it is bought. Coverage is limited to Barth syndrome and is negotiated through specialty pharmacy and prior authorization. Off-label longevity or mitochondrial uses are not covered.

Regulatory: FDA approvedVerified: Verified Sep 22, 2026
With insurance
Not published
Branded, from a pharmacy
Up to $66,000 per month
Compounded pharmacy
Not published

What each price includes, with sources

What does SS-31 (elamipretide) cost in each channel?

Prices in US dollars at the verification date. Ranges are published list or program prices where a primary source exists; notes say when a figure is a typical market range instead.

SS-31 (elamipretide) price by purchase channel
ChannelPrice (USD)Notes
With insuranceNot publishedRare disease specialty drug covered case by case for Barth syndrome, typically with prior authorization and manufacturer patient support; patient out of pocket cost is not publicly reported. [2] [4]
Branded, from a pharmacyUp to $66,000per monthForzinity was reported at approval to be priced at up to nearly $800,000 a year, which is up to about $66,000 per month; the manufacturer does not publish a list price. It is dispensed through specialty pharmacy for Barth syndrome only. [1] [2]
Compounded pharmacyNot publishedNo lawful compounded price. Elamipretide is not on the 503A bulks list, and material sold online as SS-31 for research use is not the approved drug. [3]

What is the list price of SS-31 (elamipretide)?

Forzinity received accelerated approval in September 2025 for Barth syndrome, an ultra-rare disease, and is priced accordingly. There is no lower cost licensed channel for other uses.

Does insurance cover SS-31 (elamipretide)?

Coverage is limited to Barth syndrome and is negotiated through specialty pharmacy and prior authorization. Off-label longevity or mitochondrial uses are not covered.

What changes the price?

  • Ultra-rare disease pricing for a single approved indication
  • Prior authorization and specialty pharmacy dispensing
  • Manufacturer patient support program

Frequently asked questions

How much does SS-31 (elamipretide) cost without insurance?

About $66,000 per month at the verification date, depending on the channel: branded, from a pharmacy. See the table above for what each figure includes. [1] [2]

Does insurance cover SS-31 (elamipretide)?

Coverage is limited to Barth syndrome and is negotiated through specialty pharmacy and prior authorization. Off-label longevity or mitochondrial uses are not covered. [2] [4]

What is the list price of SS-31 (elamipretide)?

Forzinity received accelerated approval in September 2025 for Barth syndrome, an ultra-rare disease, and is priced accordingly. There is no lower cost licensed channel for other uses. [1] [2]

Sources

  1. [1]Reuters report via PharmaLive: FDA cleared pricey rare disease drug over reviewer objections (Forzinity priced at up to nearly $800,000 a year)
  2. [2]FDA prescribing information for Forzinity (elamipretide) injection, 2025 label via Drugs@FDAFDA
  3. [3]FDA: Bulk drug substances used in compounding under section 503A of the FD&C Act (links to the Category 1, 2, and 3 lists and the bulks list)FDA
  4. [4]Medicare.gov: prescription drug coverage (Part D and outpatient drugs)